Volpara bid underwhelming but hard to beat: Bell Potter

Volpara bid underwhelming but hard to beat: Bell Potter
Volpara has developed a breast cancer detection system. (Image: NZME)
Pattrick Smellie
The bid by South Korean firm Lunit to take over fast-growing Wellington medical AI provider Volpara Technologies at A$1.15 (NZ$1.124) a share is no more than “good enough”, but is unlikely to be beaten, says Sydney broking house Bell Potter.Pitched at a 47.4% premium to Australian securties exchange-listed (ASX) Volpara’s closing price on Dec 13, the offer values the company, which is on the cusp of profitability after more than seven years as a publicly listed company, at a “mere US$193 million [NZ$311m]”.How...

More Markets

Market underwhelmed by Genesis outlook
Markets

Market underwhelmed by Genesis outlook

The company says it’s still on track for $500m+ ebitda in FY28.

NZME announces 12% boost in operating earnings
Markets

NZME announces 12% boost in operating earnings

The media company posted operating revenue of $165.7m for the six months to June 30.

Restaurant Brands margins undercooked in HY result
Retail

Restaurant Brands margins undercooked in HY result

Same-store sales in New Zealand fell 3.1% compared with last year.

Fonterra, Bega resolve brand dispute
Primary Sector

Fonterra, Bega resolve brand dispute

The original Mainland sale price was around $3.8b, and is now $4.22b.